Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Journal
-
- The Lancet Diabetes & Endocrinology
-
The Lancet Diabetes & Endocrinology 7 (8), 618-628, 2019-08
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360861293396228736
-
- ISSN
- 22138587
-
- Data Source
-
- Crossref